By Doug Macron

Researchers from Miragen Therapeutics and the University of Texas Southwestern Medical Center this week published data indicating that a specific microRNA, miR-15, can inhibit the production of new heart-muscle cells in mice.

The report adds to the body of evidence that Miragen and UT Southwestern researcher Eric Olson, who is a company co-founder, have generated suggesting the miRNA, as well as family member miR-195, may be targets for therapeutic intervention.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.